Abel, E. J., Culp, S. H., Tannir, N. M., Tamboli, P., Matin, S. F., & Wood, C. G. (2011). Early Primary Tumor Size Reduction Is an Independent Predictor of Improved Overall Survival in Metastatic Renal Cell Carcinoma Patients Treated With Sunitinib. Eur Urol.
Chicago ZitierstilAbel, E. Jason, Stephen H. Culp, Nizar M. Tannir, Pheroze Tamboli, Surena F. Matin, und Christopher G. Wood. "Early Primary Tumor Size Reduction Is an Independent Predictor of Improved Overall Survival in Metastatic Renal Cell Carcinoma Patients Treated With Sunitinib." Eur Urol 2011.
MLA ZitierstilAbel, E. Jason, et al. "Early Primary Tumor Size Reduction Is an Independent Predictor of Improved Overall Survival in Metastatic Renal Cell Carcinoma Patients Treated With Sunitinib." Eur Urol 2011.